Iconovo
Pre-clinicalIconovo offers the development of inhalation products, inhaler devices and dry powder formulation, and characterization of the final product.
Founded
2010
Focus
Drug Delivery
About
Iconovo offers the development of inhalation products, inhaler devices and dry powder formulation, and characterization of the final product.
Funding History
3Total raised: $27.9M
IPO$15.2MCarnegie Investment BankApr 23, 2021
Series B$8.5MFårö CapitalSep 15, 2020
Series A$4.2MSpiltanNov 15, 2018
Company Info
TypePrivate
Founded2010
LocationMalmö, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile